Armistice Capital’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-10,200,000	Closed	-$71.5K	–	207
2022 Q2	$71.5K	Buy	10,200,000 +1,828,000	+22%	+$13.4M	1.25%	18
2022 Q1	$69.4M	Sell	8,372,000 -1,200,000	-13%	-$8.48M	1.98%	14
2021 Q4	$64.8M	Sell	9,572,000 -428,000	-4%	-$2.81M	1.58%	23
2021 Q3	$53M	Hold	10,000,000	–	–	1.31%	24
2021 Q2	$57.5M	Hold	10,000,000	–	–	1.51%	24
2021 Q1	$46.1M	Hold	10,000,000	–	–	1.48%	30
2020 Q4	$33.4M	Hold	10,000,000	–	–	1.49%	26
2020 Q3	$29.7M	Buy	10,000,000 +3,800,000	+61%	+$14.9M	1.38%	34
2020 Q2	$28.6M	Buy	6,200,000 +800,000	+15%	+$3.59M	1.51%	28
2020 Q1	$20.8M	Buy	5,400,000 +300,000	+6%	+$1.23M	1.53%	33
2019 Q4	$19.1M	Buy	+5,100,000	New	+$23.8M	1.53%	31
2019 Q3	–	Sell	-5,000,000	Closed	-$19.2M	–	70
2019 Q2	$19.2M	Buy	5,000,000 +3,480,000	+229%	+$15M	1.78%	29
2019 Q1	$7.75M	Buy	1,520,000 +140,000	+10%	+$412K	0.64%	44
2018 Q4	$2.65M	Sell	1,380,000 -292,000	-17%	-$836K	0.29%	54
2018 Q3	$6.32M	Sell	1,672,000 -28,000	-2%	-$87.7K	0.52%	54
2018 Q2	$5.3M	Buy	+1,700,000	New	+$5.16M	0.46%	60